Vimarsana
Biggest News Aggregation in the World

Page 3 - Rd Division News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rd Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rd Division Today - Breaking & Trending Today

Global Hemp : GHG Successfully Restructures Debt -September 20, 2023 at 01:55 am EDT - Vimarsana News

Global Hemp : GHG Successfully Restructures Debt -September 20, 2023 at 01:55 am EDT

2023 News Releases Sep 19, 2023 GHG Successfully Restructures Debt Aug 18, 2023 GHG Announces Closing of Debt...

e-peas in strategic deal for battery free connected devices - Vimarsana News

e-peas in strategic deal for battery free connected devices

Belgian energy harvesting chip designer e-peas has signed a strategic deal with Ambient Photonics in the US for solar-powered connected devices. Combining...

New Electronics - Chicony selects Ambient Photonics to power sustainable next-generation keyboards - Vimarsana News

New Electronics - Chicony selects Ambient Photonics to power sustainable next-generation keyboards

Ambient Photonics and Chicony are to develop what they are claiming will be a revolutionary battery-free, wireless keyboard that is powered by Ambient’s breakthrough low-light solar photovoltaic (PV) cells.

Chicony Selects Ambient Photonics to Power Sustainable Next-generation Keyboards - Vimarsana News

Chicony Selects Ambient Photonics to Power Sustainable Next-generation Keyboards

Chicony to leverage Ambient’s low-light solar PV cells in groundbreaking new keyboard powered by indoor ambient light and made with recycled materials ...

Daiichi Sankyo Enhertu approved in Japan as first HER2 directed therapy for patients with HER2 mutant metastatic lung cancer - Vimarsana News

Daiichi Sankyo Enhertu approved in Japan as first HER2 directed therapy for patients with HER2 mutant metastatic lung cancer

Tokyo: Daiichi Sankyo has announced that ENHERTU (trastuzumab deruxtecan) has been approved in Japan for the treatment of adult patients with unresectable advanced or recurrent non-small cell lung...